Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 8.7B | 8.2B | 8.1B | 8.2B |
Cost of revenue | 1.7B | 1.6B | 1.7B | 1.6B |
Gross profit | 7.0B | 6.6B | 6.4B | 6.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 930.6M | 830.7M | 794.0M | 996.4M |
Other operating expenses | — | — | — | — |
Operating income | 5.8B | 5.5B | 5.4B | 5.4B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 33.3M | 134.9M | 155.4M | 150.3M |
Other income expense | -358.6M | -716.3M | 88.8M | 161.4M |
Pretax income | 5.4B | 4.6B | 5.3B | 5.4B |
Tax provision | 905.9M | 735.1M | 923.0M | 899.9M |
Net income | 4.5B | 3.9B | 4.4B | 4.5B |
Basic EPS | 2.7 | 2.3 | 2.6 | 2.7 |
Diluted EPS | 2.7 | 2.3 | 2.6 | 2.7 |
Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
EBITDA | 6.1B | 5.8B | 5.6B | 5.7B |
Net income from continuing op. | 4.5B | 3.9B | 4.4B | 4.5B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |